Research map: Proton-Pump Inhibitor use in combination with a CDK4/6 inhibitor: Is formulation the issue?

Back to the article

Papers in this map

  1. Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer · Jueun Lee · 2023 · 26 citations · Cited by this paper
  2. Patient-driven second opinions in oncology: a review · 2026 · Related
  3. Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer · Timothy J. Schieber · 2023 · 15 citations · Cited by this paper
  4. Durable response to sotorasib in KRAS G12C -mutant intrahepatic cholangiocarcinoma: a case report · 2026 · Related
  5. Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer · Kaori Takahashi · 2024 · 15 citations · Cited by this paper
  6. Neoadjuvant intent anti-programmed death-1 immunotherapy for cutaneous squamous cell carcinoma in patients with hematologic malignancy · 2026 · Related
  7. Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: prognostic effect of proton pump inhibitor use · Bo-Fang Chen · 2025 · 2 citations · Cited by this paper
  8. Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial · 2026 · Related
  9. Renal Dysfunction in Patients with CML on Long-Term First-Line TKI Therapy: A Single-Center Analysis · 2026 · Related
  10. SERENA-6 visual patient-reported outcomes & safety: camizestrant for emerging ESR1 m advanced breast cancer during first-line endocrine-basedtherapy · 2026 · Related
  11. The Role of Adjuvant Chemotherapy in Small Bowel Adenocarcinomas · 2026 · Related
  12. Oncofertility in Gastrointestinal (GI) Oncology – A Pan-European study of the patient perspective · 2026 · Related
  13. Targeted Therapies in the Management of Advanced Medullary Thyroid Cancer · 2026 · Related
  14. Phase IB/II study of alpelisib combined with paclitaxel in patients with PIK3CA -altered metastatic or recurrent gastric cancer · 2026 · Related

Source: OpenAlex (CC0)